Pure Global

Follicle-stimulating Hormone (Follicle-stimulating Hormone ) - India CDSCO Medical Device Registration

Follicle-stimulating Hormone (Follicle-stimulating Hormone ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000104_7f41b0efb92f38a78b201d61843568ce_d4ebee7fd5ae8706d14baf2196c8a7ae. This device is marketed under the brand name CLIA. The license holder is M/s. Peerless Biotech Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Follicle-stimulating Hormone (Follicle-stimulating Hormone )
UID: IMP/IVD/2023/000104_7f41b0efb92f38a78b201d61843568ce_d4ebee7fd5ae8706d14baf2196c8a7ae

Brand Name

CLIA

Device Class

Class B

Approving Authority

CDSCO

Product Information

Follicle-stimulating Hormone (CLIA) is a chemiluminescence immunoassay test for the quantitative measurement of circulating Follicle-stimulating Hormone (CLIA) in human serum or plasma, which is intended as an aid to diagnosis of Pituitary endocrine function. The assay can be used for samples over the range of 0.2mIU/mL๏ฝž200mIU/mL

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing